CELGENE INSTITUTE FOR TRANSLATIONAL RESEARCH EUROPE (CITRE), created in 2010 (United States), from 126 sister brands and 17477 competing brands. CELGENE INSTITUTE FOR TRANSLATIONAL RESEARCH EUROPE (CITRE) is owned by Celgene, listed on the stock exchange of New York The sector of CELGENE INSTITUTE FOR TRANSLATIONAL RESEARCH EUROPE (CITRE) is Drug Manufacturers.

CELGENE INSTITUTE FOR TRANSLATIONAL RESEARCH EUROPE (CITRE) is a brand of Celgene () Share price

Share price and profitability of the share Celgene (CELGENE INSTITUTE FOR TRANSLATIONAL RESEARCH EUROPE (CITRE))

Buy Celgene share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Stock market history Celgene (CELGENE INSTITUTE FOR TRANSLATIONAL RESEARCH EUROPE (CITRE))